Evidence map›Paper›PMID 40918854›Full record

ArticleCureus2025

Unveiling Psychiatric Manifestations in a Case of Moyamoya Disease.

Shahad N Alameeri, Meera A Alshehhi, Hussain Atraqchi, Mohsen M Elshamy

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shahad N AlameeriPsychiatry, Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, ARE.
Meera A AlshehhiEmergency Department, Rashid Hospital, Dubai Health, Dubai, ARE.
Hussain AtraqchiPsychiatry, Al Jalila Children's Specialty Hospital, Dubai Health, Dubai, ARE.
Mohsen M ElshamyPsychiatry, Rashid Hospital, Dubai Health, Dubai, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moyamoya disease (MMD) is a rare and progressive cerebrovascular disorder characterized by stenosis of the internal carotid arteries and their major branches, leading to the development of abnormal collateral vessels. While MMD is traditionally associated with ischemic and hemorrhagic strokes, there is increasing recognition of the psychiatric symptoms that can accompany the disease, which significantly impact patient outcomes and complicate management. This case report presents a 30-year-old female with a history of recurrent ischemic strokes, hypertension, diabetes, and dyslipidemia, who initially presented with neurological symptoms including headache, left-sided weakness, and facial deviation. Along with these neurological signs, the patient developed psychiatric symptoms, including depression and later, psychosis. After referral to the psychiatry liaison team, the patient was diagnosed with post-stroke depression, followed by the development of persecutory delusions and grandiosity. Psychiatric treatment with selective serotonin reuptake inhibitors (SSRIs) and antipsychotics led to significant improvement in mood and resolution of psychotic symptoms. This case highlights the importance of early identification and management of psychiatric manifestations in MMD patients. A multidisciplinary approach, incorporating both neurological and psychiatric interventions, is essential to optimizing patient care and improving outcomes.

Indexed as

digital subtraction angiographymoyamoya diseasepsychosisstrokevasculitis

Identifiers

PMID40918854
PMCPMC12413554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.